These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31307434)

  • 41. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized wait-list control trial to evaluate the impact of a mobile application to improve self-management of individuals with type 2 diabetes: a study protocol.
    Desveaux L; Agarwal P; Shaw J; Hensel JM; Mukerji G; Onabajo N; Marani H; Jamieson T; Bhattacharyya O; Martin D; Mamdani M; Jeffs L; Wodchis WP; Ivers NM; Bhatia RS
    BMC Med Inform Decis Mak; 2016 Nov; 16(1):144. PubMed ID: 27842539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. International guideline comparison of lifestyle management for acute coronary syndrome and type 2 diabetes mellitus: A rapid review.
    Kemp BJ; Thompson DR; Coates V; Bond S; Ski CF; Monaghan M; McGuigan K
    Health Policy; 2024 Aug; 146():105116. PubMed ID: 38943831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of lifestyle education for type 2 diabetes mellitus: Protocol for a randomized controlled trial.
    Zhu J; Chen M; Pang Y; Li S
    Medicine (Baltimore); 2021 Jan; 100(1):e24208. PubMed ID: 33429812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An Innovative Approach for Decision-Making on Designing Lifestyle Programs to Reduce Type 2 Diabetes on Dutch Population Level Using Dynamic Simulations.
    Sluijs T; Lokkers L; Özsezen S; Veldhuis GA; Wortelboer HM
    Front Public Health; 2021; 9():652694. PubMed ID: 33996729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mothers After Gestational Diabetes in Australia Diabetes Prevention Program (MAGDA-DPP) post-natal intervention: an update to the study protocol for a randomized controlled trial.
    Shih ST; Davis-Lameloise N; Janus ED; Wildey C; Versace VL; Hagger V; Asproloupos D; O'Reilly SL; Phillips PA; Ackland M; Skinner T; Oats J; Carter R; Best JD; Dunbar JA;
    Trials; 2014 Jun; 15():259. PubMed ID: 24981503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lifestyle medicine: effective cure or just snake oil?].
    Seidell JC; Halberstadt J
    Ned Tijdschr Geneeskd; 2019 Feb; 163():. PubMed ID: 30816664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Explore the risk perception and evaluate the effectiveness of competency-based intervention (CBI) on knowledge and lifestyle changes among type 2 diabetes mellitus patients.
    Sivakumar P; Ramaiah R; Alshahrani SH; Sampayan EL; Vijayakrishnan S; Jothishanmugam A; Pappiya EM; Natarajan J; Xavier JMVF; Alshahrani BY; Duraisamy K; Jothiprasad S; Ahmed RE
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6700-6708. PubMed ID: 37522681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of Diabetes in Overweight/Obese Adults through Traditional Chinese Patent Medicine: Study Protocol for a Prospective Cohort Study.
    Pang B; Zhang YY; Hu HJ; Sun Y; Cao AM; Lu CQ; Zhang WH; Ni Q
    Evid Based Complement Alternat Med; 2021; 2021():6006802. PubMed ID: 35265141
    [No Abstract]   [Full Text] [Related]  

  • 50. Identifying modifiable factors that could arrest progression to type 2 diabetes: A cluster analysis of Australian adults.
    Ryan JC; Barnes M; Cox DN
    Prev Med; 2021 Dec; 153():106796. PubMed ID: 34509524
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DIABRISK-SL trial: further consideration of age and impact of imputations.
    Gkioni E; Glonti K; Dodd S; Gamble C
    BMC Med; 2019 Jun; 17(1):121. PubMed ID: 31248404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Contributing factors of fatigue in patients with type 2 diabetes: A systematic review.
    Bi Y; Zhang L; Li X; Kan Y; Li S; Zou Y; Liu L; Yuan Y; Gong W; Zhang Y
    Psychoneuroendocrinology; 2021 Aug; 130():105280. PubMed ID: 34049018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Supporting Patients with Diabetes mellitus type 2 and Obesity in Transfer of Medically Indicated Lifestyle Changes into Everyday Life by a Planning Competence Training in a Randomized Controlled Trial].
    Arling V; Huth F; Slavchova V; Pollmann H
    Rehabilitation (Stuttg); 2020 Apr; 59(2):104-111. PubMed ID: 31108553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A healthy lifestyle - reducing T2DM risk in shift workers?
    Vetter C; Scheer FAJL
    Nat Rev Endocrinol; 2019 Apr; 15(4):194-196. PubMed ID: 30718862
    [No Abstract]   [Full Text] [Related]  

  • 55. Randomized controlled trial of the effectiveness of genetic counseling and a distance, computer-based, lifestyle intervention program for adult offspring of patients with type 2 diabetes: background, study protocol, and baseline patient characteristics.
    Nishigaki M; Tokunaga-Nakawatase Y; Nishida J; Taru C; Miyawaki I; Sanada H; Kazuma K
    J Nutr Metab; 2012; 2012():831735. PubMed ID: 22619705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Complete Health Improvement Program (CHIP): History, Evaluation, and Outcomes.
    Morton D; Rankin P; Kent L; Dysinger W
    Am J Lifestyle Med; 2016; 10(1):64-73. PubMed ID: 30202259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful Use of Virtual Shared Medical Appointments for a Lifestyle-Based Diabetes Reversal Program.
    Patel P
    Am J Lifestyle Med; 2021; 15(5):506-509. PubMed ID: 34646098
    [No Abstract]   [Full Text] [Related]  

  • 58. Correction to: Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study.
    Mounié M; Costa N; Gourdy P; Latorre C; Schirr-Bonnans S; Lagarrigue JM; Roussel H; Martini J; Buisson JC; Chauchard MC; Delaunay J; Taoui S; Poncet MF; Cosma V; Lablanche S; Coustols-Valat M; Chaillous L; Thivolet C; Sanz C; Penfornis A; Lepage B; Colineaux H; Hanaire H; Molinier L; Turnin MC; ; Benhamou PY; Rodier M; Ayon F; Puel-Olivier F; Fontaine S; Perron M; Arrivié J; Cousty-Pech F; Rouby C; Lafon F; Moura I
    Diabetes Ther; 2022 May; 13(5):1131-1132. PubMed ID: 35316510
    [No Abstract]   [Full Text] [Related]  

  • 59. Successfully Integrating Lifestyle Medicine Into Health Systems.
    Patel P; Madrid M
    Am J Lifestyle Med; 2021; 15(5):510-513. PubMed ID: 34646099
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.